Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn

Intensive Care Medicine

Volumn 22, Issue 1, 1996, Pages 71-76

  Muller W ^a   Kachel, W ^a   Lasch, P ^a   Varnholt, V ^a   Konig S A ^a  

^a Kinderklinik   (Germany)

Author keywords

Extracorporeal membrane oxygenation; Nitric oxide; Persistent pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; EXTRACORPOREAL OXYGENATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NEWBORN; PULMONARY HYPERTENSION; TIDAL VOLUME; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; EXTRACORPOREAL MEMBRANE OXYGENATION; HEMODYNAMIC PROCESSES; HUMANS; INFANT, NEWBORN; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY MECHANICS;

EID: 0030070746     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01728335     Document Type: Article

References (4)

1. Fox WW, Duara S (1983) Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 103: 505-511
2. Wung J-T, James LS, Kilchevsky E, James E (1985) Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics 76: 488-494
3. Stevenson DK, Kasting DS, Darnall RA (1979) Refractory hypoxemia associated with neonatal pulmonary disease: the use and limitations of tolazoline. J Pediatr 95: 595-599
4. Carter JM, Gerstmann DR, Clark RH, Snyder G, Cornish JD, Null DM, deLemos RA (1990) High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure. Pediatrics 85: 159-164